Searching for potential surrogate endpoints of overall survival in clinical trials for patients with prostate cancer-Reference-Cited by-同舟云学术

Searching for potential surrogate endpoints of overall survival in clinical trials for patients with prostate cancer

Published:2021-01-17 Issue:3 Volume:4 Page:
ISSN:2573-8348
Container-title:Cancer Reports
language:en
Short-container-title:Cancer Reports

Author:

Maeda Hideki¹^ORCID,Takeda Kentaro²,Urushihara Hisashi³,Kurokawa Tatsuo³

Affiliation:

1. Department of Regulatory Science, Faculty of Pharmacy Meiji Pharmaceutical University Kiyose‐city Tokyo Japan

2. Biostatistics Group, Data Science Department Astellas Pharma Global Development, Inc Northbrook Illinois USA

3. Division of Drug Development & Regulatory Science, Faculty of Pharmacy Keio University Minato‐ku Tokyo Japan

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cnr2.1334

Reference30 articles.

1. Fool’s gold, lost treasures, and the randomized clinical trial

2. Food and Drug Administration Center for Drug Evaluation and Research Center for biologics Evaluation and Research.Guidance for industry. Clinical trial endpoints for the approval of cancer drugs and biologics.2007.http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm071590.pdf. Accessed August 16 2020

3. Evaluating the evidence behind the surrogate measures included in the FDA's table of surrogate endpoints as supporting approval of cancer drugs

4. Assessment of the Clinical Benefit of Cancer Drugs Receiving Accelerated Approval

5. Acceptance of surrogate end points in clinical trials supporting approval of drugs for cancer treatment by the Japanese regulatory agency

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RECIP 1.0 Predicts Progression-Free Survival After [¹⁷⁷Lu]Lu-PSMA Radiopharmaceutical Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer;Journal of Nuclear Medicine;2024-04-18

2. Correlation between surrogate endpoints and overall survival in unresectable hepatocellular carcinoma patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis;Scientific Reports;2024-02-21

3. Assessment of Surrogate End Point Trends in Clinical Trials to Approve Oncology Drugs From 2001 to 2020 in Japan;JAMA Network Open;2023-04-28

4. Effect of docetaxel added to bicalutamide in Hormone-Naïve non-metastatic prostate cancer with rising PSA, a randomized clinical trial (SPCG-14);Acta Oncologica;2023-04-03

5. Androgen Deprivation Therapy for Prostate Cancer Influences Body Composition Increasing Risk of Sarcopenia;Nutrients;2023-03-28